Biomea Fusion Inc. (BMEA)
NASDAQ: BMEA
· Real-Time Price · USD
2.65
0.29 (12.29%)
At close: Jun 16, 2025, 3:59 PM
2.71
2.25%
After-hours: Jun 16, 2025, 07:25 PM EDT
12.29% (1D)
| Bid | 2.19 |
| Market Cap | 99.57M |
| Revenue (ttm) | 1.22M |
| Net Income (ttm) | -99.36M |
| EPS (ttm) | -3.54 |
| PE Ratio (ttm) | -0.75 |
| Forward PE | -1.55 |
| Analyst | Buy |
| Ask | 2.71 |
| Volume | 1,517,877 |
| Avg. Volume (20D) | 1,918,838 |
| Open | 2.36 |
| Previous Close | 2.36 |
| Day's Range | 2.23 - 2.74 |
| 52-Week Range | 1.29 - 13.07 |
| Beta | -0.25 |
About BMEA
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol BMEA
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for BMEA stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts1 month ago
-16.5%
Biomea Fusion shares are trading lower after the c...
Unlock content with
Pro Subscription
5 months ago
+2.3%
Biomea Fusion shares are trading higher after the company announced new preclinical data from in vivo studies of icovamenib in combination with semaglutide.
